Table 4 Relative changes (median, range) from baseline for the 26 systemic sclerosis (SSc) patients treated by autologous haematopoietic stem cell transplantation with at least 6 months follow-up after the procedure

Relative change from baseline	1 year (n = 26)	3 year (n = 20)	5 year (n = 15)
mRSS	−39% (−86%; 59%)	−72% (−100%; 33%)	−73% (−100%; −25%)
	p*<10⁻³	p*<10⁻³	p*<10⁻³
VC	4% (−13%; 77%)	3% (−32%; 93%)	−7% (−38%; 89%)
	p* = 0.019	p* = 0.044	p = 0.50
TLC	0 (−31%; 32%)	1% (−42%; 66%)	−1% (−45%; 62%)
	p = 0.98	p = 0.65	p = 0.78
FEV1	6% (−33%; 91%)	6% (−28%; 100%)	−3% (−56%; 100%)
	p*<0.047	p = 0.61	p = 0.42
DLCO	−4% (−43%; 53%)	−7% (−62%; 74%)	−9% (−59%; 64%)
	p = 0.09	p = 0.31	p = 0.41

mRSS, modified Rodnan Skin Score; VC, vital capacity; TLC, total lung capacity; FEV1, forced expiratory volume in first second; DLCO, carbon dioxide diffusion lung capacity. p*, paired Wilcoxon rank test p value.